Dopamine-induced plasticity, phospholipase D (PLD) activity and cocaine-cue behavior depend on PLD-linked metabotropic glutamate receptors in amygdala

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Krishnan, Balaji ^a   Genzer, Kathy M ^a   Pollandt, Sebastian W ^a   Liu, Jie ^a,b   Gallagher, Joel P ^a   Shinnick Gallagher, Patricia ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE; METABOTROPIC RECEPTOR; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; 2 (2' CARBOXY 3' PHENYLCYCLOPROPYL)GLYCINE; 2-(2'-CARBOXY-3'-PHENYLCYCLOPROPYL)GLYCINE; 4 AMINOBUTYRIC ACID; BENZAZEPINE DERIVATIVE; CYCLOPROPANE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; DRUG DERIVATIVE; GLYCINE; ISOENZYME; RACLOPRIDE; SK&F 81297;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSOCIATION; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PLACE PREFERENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; SYNAPTIC TRANSMISSION; ANIMAL; ANIMAL BEHAVIOR; CONDITIONING; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; MALE; MEMORY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPSE; WITHDRAWAL SYNDROME;

RATTUS;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; COCAINE; CONDITIONING (PSYCHOLOGY); CUES; CYCLOPROPANES; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCINE; ISOENZYMES; LONG-TERM POTENTIATION; MALE; MEMORY; NEURONAL PLASTICITY; PHOSPHOLIPASE D; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RECEPTORS, METABOTROPIC GLUTAMATE; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPSES;

EID: 80053188215     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025639     Document Type: Article

References (131)

1. Hyman SE, (2005) Addiction: a disease of learning and memory. Am J Psychiatry 162: 1414-1422.
2. Buffalari DM, See RE, (2010) Amygdala mechanisms of Pavlovian psychostimulant conditioning and relapse. Curr Top Behav Neurosci 3: 73-99.
3. Hyman SE, Malenka RC, Nestler EJ, (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598.
4. Koob GF, Volkow ND, (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
5. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, et al. (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19: 591-611.
6. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, et al. (2001) Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58: 334-341.
7. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, et al. (2010) Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays 32: 748-755.
8. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, et al. (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156: 11-18.
9. Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, et al. (2002) Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26: 376-386.
10. Brown EE, Robertson GS, Fibiger HC, (1992) Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J Neurosci 12: 4112-4121.
11. Tran-Nguyen LT, Fuchs RA, Coffey GP, Baker DA, O'Dell LE, et al. (1998) Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19: 48-59.
12. See RE, Fuchs RA, Ledford CC, McLaughlin J, (2003) Drug addiction, relapse, and the amygdala. Ann N Y Acad Sci 985: 294-307.
13. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, et al. (1999) Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci 877: 412-438.
14. McLaughlin J, See RE, (2003) Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 168: 57-65.
15. Meil WM, See RE, (1997) Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res 87: 139-148.
16. Whitelaw RB, Markou A, Robbins TW, Everitt BJ, (1996) Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology (Berl) 127: 213-224.
17. Ciccocioppo R, Sanna PP, Weiss F, (2001) Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci U S A 98: 1976-1981.
18. Kantak KM, Black Y, Valencia E, Green-Jordan K, Eichenbaum HB, (2002) Dissociable effects of lidocaine inactivation of the rostral and caudal basolateral amygdala on the maintenance and reinstatement of cocaine-seeking behavior in rats. J Neurosci 22: 1126-1136.
19. Kruzich PJ, See RE, (2001) Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior. J Neurosci 21: RC155.
20. Shalev U, Grimm JW, Shaham Y, (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1-42.
21. Carr GD, Fibiger HD, Phillips HG, (1989) Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ, editors. The Neurological Basis of Reward Oxford Science Publications pp. 284-317.
22. Brown EE, Fibiger HC, (1993) Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference. Psychopharmacology (Berl) 113: 123-130.
23. Fuchs RA, Weber SM, Rice HJ, Neisewander JL, (2002) Effects of excitotoxic lesions of the basolateral amygdala on cocaine-seeking behavior and cocaine conditioned place preference in rats. Brain Res 929: 15-25.
24. Li YQ, Li FQ, Wang XY, Wu P, Zhao M, et al. (2008) Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci 28: 13248 (PMCID In process).
25. Fibiger HC, Phillips AG, Brown EE, (1992) The neurobiology of cocaine-induced reinforcement. Ciba Found Symp 166: 96-111.
26. See RE, Kruzich PJ, Grimm JW, (2001) Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl) 154: 301-310.
27. Weiss F, Martin-Fardon R, Ciccocioppo R, Kerr TM, Smith DL, et al. (2001) Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues. Neuropsychopharmacology 25: 361-372.
28. Maggos CE, Spangler R, Zhou Y, Schlussman SD, Ho A, et al. (1997) Quantitation of dopamine transporter mRNA in the rat brain: mapping, effects of "binge" cocaine administration and withdrawal. Synapse 26: 55-61.
29. Hurd YL, Ponten M, (2000) Cocaine self-administration behavior can be reduced or potentiated by the addition of specific dopamine concentrations in the nucleus accumbens and amygdala using in vivo microdialysis. Behav Brain Res 116: 177-186.
30. Wilson JM, Nobrega JN, Corrigall WA, Coen KM, Shannak K, et al. (1994) Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine. Brain Res 668: 39-45.
31. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, et al. (2000) Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci U S A 97: 4321-4326.
32. Callahan PM, Bryan SK, Cunningham KA, (1995) Discriminative stimulus effects of cocaine: antagonism by dopamine D1 receptor blockade in the amygdala. Pharmacol Biochem Behav 51: 759-766.
33. Caine SB, Heinrichs SC, Coffin VL, Koob GF, (1995) Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 692: 47-56.
34. McGregor A, Roberts DC, (1993) Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624: 245-252.
35. Grimm JW, Shaham Y, Hope BT, (2002) Effect of cocaine and sucrose withdrawal period on extinction behavior, cue-induced reinstatement, and protein levels of the dopamine transporter and tyrosine hydroxylase in limbic and cortical areas in rats. Behav Pharmacol 13: 379-388.
36. Brinley-Reed M, McDonald AJ, (1999) Evidence that dopaminergic axons provide a dense innervation of specific neuronal subpopulations in the rat basolateral amygdala. Brain Res 850: 127-135.
37. Hurd YL, McGregor A, Ponten M, (1997) In vivo amygdala dopamine levels modulate cocaine self-administration behaviour in the rat: D1 dopamine receptor involvement. Eur J Neurosci 9: 2541-2548.
38. Scibilia RJ, Lachowicz JE, Kilts CD, (1992) Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11: 146-154.
39. Huang YY, Kandel ER, (1995) D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci U S A 92: 2446-2450.
40. Huang YY, Simpson E, Kellendonk C, Kandel ER, (2004) Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Proc Natl Acad Sci U S A 101: 3236-3241.
41. Bissiere S, Humeau Y, Luthi A, (2003) Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat Neurosci 6: 587-592.
42. Goussakov I, Chartoff EH, Tsvetkov E, Gerety LP, Meloni EG, et al. (2006) LTP in the lateral amygdala during cocaine withdrawal. European Journal of Neuroscience 23: 239-250.
43. Krishnan B, Centeno M, Pollandt S, Fu Y, Genzer K, et al. (2010) Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal. Eur J Neurosci 31: 1027-1042.
44. Olive MF, (2009) Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev 2: 83-989.
45. Backstrom P, Hyytia P, (2006) Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology 31: 778-786.
46. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, et al. (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4: 873-874.
47. Lu L, Uejima JL, Gray SM, Bossert JM, Shaham Y, (2007) Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving. Biol Psychiatry 61: 591-598.
48. Xie X, Ramirez DR, Lasseter HC, Fuchs RA, (2010) Effects of mGluR1 antagonism in the dorsal hippocampus on drug context-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) 208: 1-11.
49. Anwyl R, (2009) Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharmacology 56: 735-740.
50. Sidiropoulou K, Lu FM, Fowler MA, Xiao R, Phillips C, et al. (2009) Dopamine modulates an mGluR5-mediated depolarization underlying prefrontal persistent activity. Nat Neurosci 12: 190-199.
51. Schotanus SM, Chergui K, (2008) Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens. Neuropharmacology 54: 837-844.
52. Poisik OV, Smith Y, Conn PJ, (2007) D1- and D2-like dopamine receptors regulate signaling properties of group I metabotropic glutamate receptors in the rat globus pallidus. Eur J Neurosci 26: 852-862.
53. Cabello N, Gandia J, Bertarelli DCG, Watanabe M, Lluis C, et al. (2009) Metabotropic glutamate type 5, dopamine D-2 and adenosine A(2a) receptors form higher-order oligomers in living cells. Journal of Neurochemistry 109: 1497-1507.
54. Schmidt K, Krishnan B, Xia Y, Sun A, Orozco-Cabal L, et al. (2011) Cocaine withdrawal reduces group I mGluR-mediated long-term potentiation via decreased GABAergic transmission in the amygdala. European Journal of Neuroscience 34: 177-189.
55. Cockcroft S, (2001) Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci 58: 1674-1687.
56. Exton JH, (2002) Regulation of phospholipase D. FEBS Lett 531: 58-61.
57. Attucci S, Albani-Torregrossa S, Moroni F, Pellegrini-Giampietro DE, (2001) Metabotropic glutamate receptors stimulate phospholipase D via different pathways in the adult and neonate rat hippocampus. Neurochem Res 26: 1151-1155.
58. Cai D, Zhong M, Wang R, Netzer WJ, Shields D, et al. (2006) Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci U S A 103: 1936-1940.
59. Cai D, Netzer WJ, Zhong M, Lin Y, Du G, et al. (2006) Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. Proc Natl Acad Sci U S A 103: 1941-1946.
60. Disse J, Vitale N, Bader MF, Gerke V, (2009) Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells. Blood 113: 973 (PMCID In process).
61. Frohman MA, Sung TC, Morris AJ, (1999) Mammalian phospholipase D structure and regulation. Biochim Biophys Acta 1439: 175-186.
62. Holler T, Cappel E, Klein J, Loffelholz K, (1993) Glutamate activates phospholipase D in hippocampal slices of newborn and adult rats. J Neurochem 61: 1569-1572.
63. Holler T, Klein J, Loffelholz K, (1994) Phospholipase C and phospholipase D are independently activated in rat hippocampal slices. Biochem Pharmacol 47: 411-414.
64. Kanaho Y, Funakoshi Y, Hasegawa H, (2009) Phospholipase D signalling and its involvement in neurite outgrowth. 1791 Biochim Biophys Acta898-904 (PMCID In process).
65. Kawasaki S, Watanabe S, Kimura S, Fujita R, Ochiai J, et al. (2008) Regulation of dopamine-induced Na+ current response by small G-protein RhoB or C and phospholipase D in Aplysia neurons. Neurosci Res 60: 147 (PMCID In process).
66. Klein J, (2005) Functions and pathophysiological roles of phospholipase D in the brain. J Neurochem 94: 1473-1487.
67. Oliveira TG, Di Paolo G, (2010) Phospholipase D in brain function and Alzheimer's disease. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 1801: 799-805 (PMCID In process).
68. Oliveira TG, Chan RB, Tian HS, Laredo M, Shui GH, et al. (2010) Phospholipase D2 Ablation Ameliorates Alzheimer's Disease-Linked Synaptic Dysfunction and Cognitive Deficits. Journal of Neuroscience 30: 16419-16428 (PMCID In process).
69. Peng X, Frohman MA, (2011) Mammalian Phospholipase D Physiological and Pathological Roles. Acta Physiol (Oxf)-(PMCID In Process).
70. Hughes WE, Elgundi Z, Huang P, Frohman MA, Biden TJ, (2004) Phospholipase D1 regulates secretagogue-stimulated insulin release in pancreatic beta-cells. J Biol Chem 279: 27534-27541.
71. Huang P, Altshuller YM, Hou JC, Pessin JE, Frohman MA, (2005) Insulin-stimulated plasma membrane fusion of Glut4 glucose transporter-containing vesicles is regulated by phospholipase D1. Mol Biol Cell 16: 2614-2623.
72. Du G, Huang P, Liang BT, Frohman MA, (2004) Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol Biol Cell 15: 1024-1030.
73. Humeau Y, Vitale N, Chasserot-Golaz S, Dupont JL, Du G, et al. (2001) A role for phospholipase D1 in neurotransmitter release. Proc Natl Acad Sci U S A 98: 15300-15305.
74. Boss V, Conn PJ, (1992) Metabotropic excitatory amino acid receptor activation stimulates phospholipase D in hippocampal slices. J Neurochem 59: 2340-2343.
75. Boss V, Nutt KM, Conn PJ, (1994) L-cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity. Mol Pharmacol 45: 1177-1182.
76. Klein J, Iovino M, Vakil M, Shinozaki H, Loffelholz K, (1997) Ontogenetic and pharmacological studies on metabotropic glutamate receptors coupled to phospholipase D activation. Neuropharmacology 36: 305-311.
77. Pellegrini-Giampietro DE, Torregrossa SA, Moroni F, (1996) Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus. Br J Pharmacol 118: 1035-1043.
78. Shinomura T, del Rio E, Breen KC, Downes CP, McLaughlin M, (2000) Activation of phospholipase D by metabotropic glutamate receptor agonists in rat cerebrocortical synaptosomes. Br J Pharmacol 131: 1011-1018.
79. Pellicciari R, Marinozzi M, Costantino G, Natalini B, Moroni F, et al. (1999) (2R,1′S,2′R,3′S)-2-(2′-Carboxy-3′-phenylcyclopropyl)glycine (PCCG-13), the first potent and selective competitive antagonist of phospholipase D-coupled metabotropic glutamate receptors: asymmetric synthesis and preliminary biological properties. J Med Chem 42: 2716-2720.
80. Albani-Torregrossa S, Attucci S, Marinozzi M, Pellicciari R, Moroni F, et al. (1999) Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1′S,2′R,3′S)-2-(2′-carboxy-3′-phenylcyclopropyl)glycine versus 3, 5-dihydroxyphenylglycine. Mol Pharmacol 55: 699-707.
81. Rico MJ, Merlin LR, (2004) Evidence that phospholipase D activation prevents group I mGluR-induced persistent prolongation of epileptiform bursts. J Neurophysiol 91: 2385-2388.
82. Matsumoto M, Sasaki K, Sato M, Shozushima M, Takashima K, (1988) Dopamine-induced depolarizing responses associated with negative slope conductance in LB-cluster neurones of Aplysia. J Physiol 407: 199-213.
83. Gorbatyuk OS, Li S, Nha NF, Manfredsson FP, Kondrikova G, et al. (2010) alpha-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. Mol Ther 18: 1758-1768.
84. Groc L, Choquet D, Chaouloff F, (2008) The stress hormone corticosterone conditions AMPAR surface trafficking and synaptic potentiation. Nat Neurosci 11: 868-870.
85. Le Vasseur M, Ran I, Lacaille JC, (2008) Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus. Neuroscience 151: 28-42.
86. Otmakhov N, Tao-Cheng JH, Carpenter S, Asrican B, Dosemeci A, et al. (2004) Persistent accumulation of calcium/calmodulin-dependent protein kinase II in dendritic spines after induction of NMDA receptor-dependent chemical long-term potentiation. J Neurosci 24: 9324-9331.
87. Fu Y, Pollandt S, Liu J, Krishnan B, Genzer K, et al. (2007) Long-term potentiation (LTP) in the central amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptors. J Neurophysiol 97: 937-941.
88. Liu J, Yu B, Neugebauer V, Grigoriadis DE, Rivier J, et al. (2004) Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission. J Neurosci 24: 4020-4029.
89. Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, et al. (2006) Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur J Neurosci 24: 1733-1743.
90. Marowsky A, Yanagawa Y, Obata K, Vogt KE, (2005) A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron 48: 1025-1037.
91. Senogles SE, (2000) The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Mol Pharmacol 58: 455-462.
92. Voulalas PJ, Holtzclaw L, Wolstenholme J, Russell JT, Hyman SE, (2005) Metabotropic glutamate receptors and dopamine receptors cooperate to enhance extracellular signal-regulated kinase phosphorylation in striatal neurons. J Neurosci 25: 3763-3773.
93. Abe T, Sugihara H, Nawa H, Shigemoto R, Mizuno N, et al. (1992) Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J Biol Chem 267: 13361-13368.
94. Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S, (1991) Sequence and expression of a metabotropic glutamate receptor. Nature 349: 760-765.
95. Houamed KM, Kuijper JL, Gilbert TL, Haldeman BA, O'Hara PJ, et al. (1991) Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain. Science 252: 1318-1321.
96. Burgdorf C, Schafer U, Richardt G, Kurz T, (2010) U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanism. J Cardiovasc Pharmacol 55: 555-559.
97. Hall RA, (2004) Co-immunoprecipitation as a strategy to evaluate receptor-receptor or receptor-protein interactions. In: George SR, O'Dowd BF, editors. Receptor Biochemistry and Methodology John Wiley and Sons pp. 165-178.
98. Kobayashi M, Kanfer JN, (1987) Phosphatidylethanol formation via transphosphatidylation by rat brain synaptosomal phospholipase D. J Neurochem 48: 1597-1603.
99. Orozco-Cabal L, Liu J, Pollandt S, Schmidt K, Shinnick-Gallagher P, et al. (2008) Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration. J Neurosci 28: 529-542.
100. Zhang JC, Lau PM, Bi GQ, (2009) Gain in sensitivity and loss in temporal contrast of STDP by dopaminergic modulation at hippocampal synapses. Proceedings of the National Academy of Sciences of the United States of America 106: 13028-13033.
101. Mottola DM, Laiter S, Watts VJ, Tropsha A, Wyrick SD, et al. (1996) Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping. J Med Chem 39: 285-296.
102. Charifson PS, Bowen JP, Wyrick SD, Hoffman AJ, Cory M, et al. (1989) Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands. J Med Chem 32: 2050-2058.
103. Ryman-Rasmussen JP, Nichols DE, Mailman RB, (2005) Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. Mol Pharmacol 68: 1039-1048.
104. Luscher C, Huber KM, (2010) Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65: 445-459.
105. Otani S, Auclair N, Desce JM, Roisin MP, Crepel F, (1999) Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J Neurosci 19: 9788-9802.
106. Pape HC, (2005) GABAergic neurons: gate masters of the amygdala, mastered by dopamine. Neuron 48: 877-879.
107. Rosenkranz JA, Grace AA, (1999) Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci 19: 11027-11039.
108. Rosenkranz JA, Grace AA, (2002) Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci 22: 324-337.
109. Kroner S, Rosenkranz JA, Grace AA, Barrionuevo G, (2005) Dopamine modulates excitability of basolateral amygdala neurons in vitro. J Neurophysiol 93: 1598-1610.
110. Royer S, Martina M, Pare D, (1999) An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J Neurosci 19: 10575-10583.
111. Liu QS, Pu L, Poo MM, (2005) Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 437: 1027-1031.
112. McGinty JF, Shi XD, Schwendt M, Saylor A, Toda S, (2008) Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem 104: 1440-1449.
113. Laurier LG, Corrigall WA, George SR, (1994) Dopamine receptor density, sensitivity and mRNA levels are altered following self-administration of cocaine in the rat. Brain Res 634: 31-40 0006-8993(94)90255-0 [pii].
114. Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN, (2008) Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens. Brain Res 1198: 44-54.
115. Jordan BA, Devi LA, (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399: 697-700.
116. Romano C, Sesma MA, McDonald CT, O'Malley K, van den Pol AN, et al. (1995) Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355: 455-469.
117. Rashid AJ, O'Dowd BF, Verma V, George SR, (2007) Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends Pharmacol Sci 28: 551-555.
118. Colley WC, Altshuller YM, Sue-Ling CK, Copeland NG, Gilbert DJ, et al. (1997) Cloning and expression analysis of murine phospholipase D1. Biochem J 326 (Pt 3): 745-753.
119. Kim M, Moon C, Kim H, Shin MK, Min DS, et al. (2010) Developmental levels of phospholipase D isozymes in the brain of developing rats. Acta Histochemica 112: 81-91.
120. Hayakawa K, Nakashima S, Ito Y, Mizuta K, Miyata H, et al. (1999) Increased expression of phospholipase D1 mRNA during cAMP- or NGF-induced differentiation in PC12 cells. Neurosci Lett 265: 127-130.
121. Watanabe H, Yokozeki T, Yamazaki M, Miyazaki H, Sasaki T, et al. (2004) Essential role for phospholipase D2 activation downstream of ERK MAP kinase in nerve growth factor-stimulated neurite outgrowth from PC12 cells. J Biol Chem 279: 37870-37877.
122. Watanabe H, Yamazaki M, Miyazaki H, Arikawa C, Itoh K, et al. (2004) Phospholipase D2 functions as a downstream signaling molecule of MAP kinase pathway in L1-stimulated neurite outgrowth of cerebellar granule neurons. J Neurochem 89: 142-151.
123. Zhang Y, Huang P, Du G, Kanaho Y, Frohman MA, et al. (2004) Increased expression of two phospholipase D isoforms during experimentally induced hippocampal mossy fiber outgrowth. Glia 46: 74-83.
124. Zhang Y, Kanaho Y, Frohman MA, Tsirka SE, (2005) Phospholipase D1-promoted release of tissue plasminogen activator facilitates neurite outgrowth. J Neurosci 25: 1797-1805.
125. Campeau S, Davis M, (1995) Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 15: 2301-2311.
126. Shimosato K, Ohkuma S, (2000) Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and methamphetamine. Pharmacol Biochem Behav 66: 285-292.
127. Paxinos, G, Watson C, (1998) The Rat Brain in Stereotaxic Coordinates. San Diego, CA Academic Press.
128. Gardiner TW, Toth LA, (1999) Stereotactic Surgery and Long-Term Maintenance of Cranial Implants in Research Animals. Contemp Top Lab Anim Sci 38: 56-63.
129. Roselli F, Hutzler P, Wegerich Y, Livrea P, Almeida OF, (2009) Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways. PLoS One 4: e6011.
130. Goffin D, Aarum J, Schroeder JE, Jovanovic JN, Chuang TT, (2008) D1-like dopamine receptors regulate GABAA receptor function to modulate hippocampal neural progenitor cell proliferation. J Neurochem 107: 964-975.
131. Luedtke RR, Griffin SA, Conroy SS, Jin X, Pinto A, et al. (1999) Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes. J Neuroimmunol 101: 170-187.